Literature DB >> 22380739

Evaluation of perirenal fat as a predictor of cT 1a renal cortical neoplasm histopathology and surgical outcomes.

Zhamshid Okhunov1, Adam C Mues, Myriam Kline, Georgios Haramis, Bin Xu, Gabriella Mirabile, Manish Vira, Jaime Landman.   

Abstract

BACKGROUND AND
PURPOSE: With the increasing detection of small renal cortical neoplasms (RCNs), the preoperative prediction of histopathology has become increasingly important. Because perirenal fat (PF) is known to be metabolically active, we evaluated PF as a predictor of renal tumor histopathology. PATIENTS AND METHODS: We retrospectively evaluated patients who underwent laparoscopic nephron-sparing procedures for cT(1a) RCN at two institutions. PF was measured using the digital measuring tool function on standard imaging software, at the level of the renal hilum as the perpendicular distance between the posterior surface of the kidney and the external margin of the psoas muscle. The Mann-Whitney test and logistic regression were used to examine PF, selected demographic, clinical, and operative parameters, and their association with tumor histopathology.
RESULTS: Data from 250 patients were included in this study. There were 157 (63%) men and 93 (37%) women with a median body mass index (BMI) of 28 kg/m(2). Median tumor size was 2.4 cm, and the median PF distance was 12 mm. Significant correlations were noted between PF and sex and BMI. No significant correlations were found between PF and the operative parameters. Results of a multivariate logistic regression analysis revealed that PF (P<0.01), age (P<0.04), and tumor location (P<0.04) were significant predictors of clear-cell renal-cell carcinoma (RCC) histopathology.
CONCLUSIONS: In this study, PF, location of tumor, and age were significant predictors of clear-cell RCC histopathology. The correlation of PF and histopathology may be useful in preoperative decision-making and surgical planning in the management of small RCN.

Entities:  

Mesh:

Year:  2012        PMID: 22380739     DOI: 10.1089/end.2011.0599

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  7 in total

1.  Association between visceral and subcutaneous adiposity and clinicopathological outcomes in non-metastatic clear cell renal cell carcinoma.

Authors:  Roy Mano; A Ari Hakimi; Emily C Zabor; Marta A Bury; Olivio F Donati; Christoph A Karlo; Wassim M Bazzi; Helena Furberg; Paul Russo
Journal:  Can Urol Assoc J       Date:  2014-09       Impact factor: 1.862

2.  Three-dimensional evaluation of perirenal fat volume in patients with nephrolithiasis.

Authors:  Daniel J Lama; Shoaib Safiullah; Albert Yang; Zhamshid Okhunov; Jaime Landman; Ralph V Clayman
Journal:  Urolithiasis       Date:  2018-03-02       Impact factor: 3.436

3.  Effect of perineoplasm perinephric adipose tissues on migration of clear cell renal cell carcinoma cells: a potential role of WNT signaling.

Authors:  Xiaolin Zi; Achim Lusch; Christopher A Blair; Zhamshid Okhunov; Noriko N Yokoyama; Shuman Liu; Molly Baker; Victor Huynh; Jaime Landman
Journal:  Oncotarget       Date:  2016-08-16

4.  Obesity, Weight Loss, Lifestyle Interventions, and Autosomal Dominant Polycystic Kidney Disease.

Authors:  Cortney Steele; Kristen Nowak
Journal:  Kidney Dial       Date:  2022-03-04

Review 5.  The evolving view of thermogenic fat and its implications in cancer and metabolic diseases.

Authors:  Xinpeng Yin; Yuan Chen; Rexiati Ruze; Ruiyuan Xu; Jianlu Song; Chengcheng Wang; Qiang Xu
Journal:  Signal Transduct Target Ther       Date:  2022-09-16

6.  Comparison of perinephric fat measurements between malignant and benign renal tumours.

Authors:  Jui-Peng Tsai; Dao-Chen Lin; Wei-Ming Huang; Marcelo Chen; Yi-Hsuan Chen
Journal:  J Int Med Res       Date:  2022-09       Impact factor: 1.573

7.  Mayo Adhesive Probability (MAP) score of non-donated kidney aids in predicting post-operative renal function following donor nephrectomy.

Authors:  Katherine J Cockerill; Amanda E Kahn; Stacy M Young; Colleen T Ball; Martin L Mai; C Burcin Taner; Dana K Perry; David D Thiel
Journal:  BMC Urol       Date:  2020-08-17       Impact factor: 2.264

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.